DR. ASHWIN H SHAH MD NPI 1710983812

NPI Details

DR. Ashwin H Shah, MD is an urology in Monroe, MI with 49 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Ashwin H Shah, MD NPI is 1710983812. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

730 N MACOMB ST
STE 319
MONROE, MI
ZIP 48162
Phone: (734) 241-3900
Fax: (734) 241-3538

The NPI 1710983812 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Incision of urethra in male using an endoscope (HCPCS:52275)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Dilation of bladder using an endoscope under general or spinal anesthesia (HCPCS:52260)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Unclassified drugs (HCPCS:J3490)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Incision of urethra in female using an endoscope (HCPCS:52270)
• Placement of hormone pellet under skin (HCPCS:11980)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Dilation of bladder using an endoscope (HCPCS:52265)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope (HCPCS:52351)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Biopsy of bladder using an endoscope (HCPCS:52204)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)

The enumeration date for this NPI number is 6/23/2005 and was last updated on 4/15/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.